Guardant Health
GH
#3559
Rank
โ‚น258.94 B
Marketcap
โ‚น2,105
Share price
-1.18%
Change (1 day)
-7.66%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -โ‚น402.93

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น411.92. In 2022 the company made an earnings per share (EPS) of -โ‚น536.92 a decrease over its 2021 EPS that were of -โ‚น335.58.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น402.93-24.96%
2022-โ‚น536.9260%
2021-โ‚น335.5855.04%
2020-โ‚น216.45207.14%
2019-โ‚น70.47-19.81%
2018-โ‚น87.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น404.37-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.02-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA